Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Excessive thyroid hormone replacement therapy

J Nuovo1, A Ellsworth, D B Christensen

  • 1Department of Family Practice, School of Medicine, University of California, Davis, USA.

The Journal of the American Board of Family Practice
|November 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Neuropathological and cerebrospinal fluid correlates of choroid plexus inflammation in progressive multiple sclerosis.

Brain pathology (Zurich, Switzerland)·2024
Same author

An enquiry into the usefulness of an information portal for Deaf and hard of hearing people prior to x-ray examinations and improvement ideas.

Radiography (London, England : 1995)·2024
Same author

Are intravitreal injections essential during the COVID-19 pandemic? Global preferred practice patterns and practical recommendations.

International journal of retina and vitreous·2022
Same author

Canadian Surgery Forum.

Canadian journal of surgery. Journal canadien de chirurgie·2022
Same author

Public health information on COVID-19 for international travellers: lessons learned from a mixed-method evaluation.

Public health·2021
Same author

Erratum: Evolution of π^{0} Suppression in Au+Au Collisions from sqrt[s_{NN}]=39 to 200 GeV [Phys. Rev. Lett. 109, 152301 (2012)].

Physical review letters·2020

Excessive thyroid hormone replacement is common, leading to iatrogenic hyperthyroxinemia. Monitoring thyroid-stimulating hormone (TSH) is crucial to prevent overdosing and potential long-term health complications.

Area of Science:

  • Endocrinology
  • Pharmacology

Background:

  • Excessive thyroid hormone replacement can cause serious metabolic complications like osteoporosis.
  • Increased thyroid hormone bioavailability and sensitive TSH assays heighten the risk of iatrogenic hyperthyroxinemia.
  • Changes in thyroid hormone formulations and testing sensitivity may influence the incidence of over-replacement.

Purpose of the Study:

  • To determine the frequency of excessive thyroid hormone prescribing.
  • To examine the impact of formulation potency and assay sensitivity on iatrogenic hyperthyroxinemia incidence.

Main Methods:

  • Retrospective chart review of patients on thyroid hormone replacement therapy.
  • Data collected included thyroid medication details and serum T4 and TSH levels.
  • Comparison of data from two distinct time periods (1975-1981 and 1982-1989).

Related Experiment Videos

Main Results:

  • Serum T4 levels showed no significant difference between the two periods.
  • Significant decreases in serum TSH levels and levothyroxine dosage were observed in the later period.
  • A higher percentage of patients exhibited suppressed TSH levels in the 1982-1989 period compared to 1975-1981.

Conclusions:

  • Iatrogenic hyperthyroxinemia due to excessive thyroid hormone replacement is frequent.
  • Clinicians must recognize this issue and implement monitoring strategies.
  • Periodic TSH monitoring is recommended to minimize overdosing and associated long-term risks.